Beginning of end of Covid-19, says Harsh Vardhan ahead of vaccination drive
A day before a massive countrywide vaccination drive against coronavirus is set to commence, Union health minister Harsh Vardhan on Friday said the step is "probably the beginning of the end" of Covid-19. I say, this is probably the beginning of the end of COVID now which is going to start tomorrow," Vardhan, who is also Science and Technology and Earth Sciences minister, said.
Biden taps former FDA chief Kessler to lead vaccine science
President-elect Joe Biden has picked a former Food and Drug commissioner to lead vaccine science in his drive to put 100 million shots into the arms of Americans in his administration's first 100 days and stem the Covid-19 pandemic. Kessler will work out of the federal Department of Health and Human Services, assuming responsibility for the scientific side of Operation Warp Speed, an effort launched under the Trump administration to rapidly develop vaccines and treatments.
My COVID Story: Hydroxychloroquine led to swelling in my whole body
Sheethal V contracted COVID and underwent severe body pain and throat ache. While battling with COVID, she got the shock of her life when a rheumatologist diagnosed her of reactive arthritis. Here is how she fought the virus...
Small Wonder: How a 11-year-old Oliver is taking the chess world by storm
Even as his schoolmates at the 5th grade of New York's Speyer Legacy School spent time either attending online classes during the months of covid-19 lockdown or remained glued to cartoons on the television or mobile phones, Oliver Boydell had a different homework to complete.
DNA test can help identify pneumonia in Covid patients: Study
A team of scientists and doctors from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust have developed a DNA test which they claim will quickly identify secondary infections in Covid-19 patients, who have double the risk of developing pneumonia while on ventilation.
Rumors of available COVID-19 vaccines spark frenzy in New York City
Rumors on social media of soon-to-expire COVID-19 vaccines up for grabs at the Brooklyn Army Terminal sparked a frenzy of people rushing to the site in the hopes of scoring a shot Thursday evening — before the city showed up with a dose of reality.
South African scientists discover new chemicals that kill malaria parasite
Africa|: Johannesburg: South African scientists have discovered chemical compounds that could potentially be used for a new line of drugs to treat malaria and even kill the parasite in its infectious stage, which most available drugs do not. The research led by the University of Pretoria, published in the Nature Communications journal this week, found that chemical compounds undergoing trials for the treatment of tuberculosis and cancer -- the JmjC inhibitor ML324 and the antitubercular clinical candidate SQ109 -- can kill the disease-causing parasite at a stage when it normally infects others. The World Health Organisation said in November that deaths from malaria due to disruption during the coronavirus pandemic to services designed to tackle the mosquito-borne disease will far exceed those killed by COVID-19 in sub-Saharan Africa. Malaria killed more than 400,000 people across the world in 2019, according to the latest WHO figures, all but a few thousand of them in Africa. There were 229 million cases across the world, 215 million of them on the continent. "Our innovation was around finding compounds that are able to block the transmissible stages and we if we are able to do so then we stop the spread of malaria," Research Chair in Sustainable Malaria Control and biochemistry professor Lyn-Marie Birkholtz, who was part of the team, told Reuters on Friday. Most drugs kill malaria as it gets established in the liver or after it has infected red blood cells, but cannot tackle it once the parasite is released from the cells, which is when it is transmissible to other people via mosquito bites, she said. The one drug that can have an effect during the transmissible phase, primaquine, is not widely used, owing to concerns about side effects. "If we can develop these compounds ... then we have an additional new tool that we can use to eliminate malaria," said Birkholtz. More tests would still need to be carried out before the compounds could be approved as a treatment for malaria but the breakthrough would also address concerns over drug resistance, she said.